Abstract Eicosanoids are major players in the pathogenesis of several common diseases, with either overproduction or imbalance (e.g.between thromboxanes and prostacyclins) often leading to worsening of disease symptoms.Both the total rate of eicosanoid production and the balance between eicosanoids with opposite effects are strongly dependent on di